Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Clinical Trial of MI078 Capsules for the Treatment of Patients With Postpartum Depression

NCT07721961 is registered in ClinicalTrials.gov with Nanjing Minova Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07721961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07721961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Clinical Trial of MI078 Capsules for the Treatment of Patients With Postpartum Depression
Lead sponsor
Nanjing Minova Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Recruiting
Start date
July 10, 2026
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum depression (ppd)